Drug vs class-specific black box warnings: does one bad drug spoil the bunch?
作者信息
Dusetzina Stacie B, Caleb Alexander G
出版信息
J Gen Intern Med. 2011 Jun;26(6):570-2. doi: 10.1007/s11606-011-1714-9.
Abstract
摘要
相似文献
1
Drug vs class-specific black box warnings: does one bad drug spoil the bunch?药物与特定类别黑框警告：一种不良药物会连累同类药物吗？
J Gen Intern Med. 2011 Jun;26(6):570-2. doi: 10.1007/s11606-011-1714-9.
2
Different black box warning labeling for same-class drugs.不同同类药物的黑框警告标签。
J Gen Intern Med. 2011 Jun;26(6):603-10. doi: 10.1007/s11606-011-1633-9. Epub 2011 Feb 1.
3
Pharmacy students' knowledge of black box warnings.药学专业学生对黑框警告的认知。
Am J Pharm Educ. 2010 Feb 10;74(1):5. doi: 10.5688/aj740105.
4
The Use of Social Media in Detecting Drug Safety-Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review.社交媒体在发现药物安全性相关新黑框警告、标签变化或撤市中的应用：范围综述。
JMIR Public Health Surveill. 2021 Jun 28;7(6):e30137. doi: 10.2196/30137.
5
Black box warnings-implications in practice.
Geriatr Nurs. 2008 Nov-Dec;29(6):402-9. doi: 10.1016/j.gerinurse.2008.09.005.
6
Medication guides scrutinized.药物指南审查。
Am J Health Syst Pharm. 2007 Jul 15;64(14):1464-6. doi: 10.2146/news070067.
7
Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.黑框警告禁忌合并用药：三种主要药物相互作用筛选程序的一致性。
Ann Pharmacother. 2010 Jan;44(1):28-34. doi: 10.1345/aph.1M475. Epub 2009 Dec 29.
8
Black-Box Warnings of Antiseizure Medications: What is Inside the Box?抗癫痫药物的黑框警告：盒子里装的是什么？
Pharmaceut Med. 2023 May;37(3):233-250. doi: 10.1007/s40290-023-00475-x. Epub 2023 Apr 29.
9
How to end med confusion.如何终结用药困惑。
Hosp Health Netw. 2007 Jan;81(1):8, 10.
10
Medication Safety: What Nurses Should Know About Black Box Warnings.用药安全：护士应了解的黑框警告内容。
J Psychosoc Nurs Ment Health Serv. 2017 Jun 1;55(6):11-15. doi: 10.3928/02793695-20170519-01.
本文引用的文献
1
The safety of thiazolidinediones.噻唑烷二酮类药物的安全性。
Expert Opin Drug Saf. 2011 May;10(3):419-28. doi: 10.1517/14740338.2011.534982. Epub 2011 Mar 3.
2
Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.噻唑烷二酮类药物与 2 型糖尿病或糖尿病高危患者心力衰竭风险：安慰剂对照随机临床试验的荟萃分析和荟萃回归分析。
Am J Cardiovasc Drugs. 2011;11(2):115-28. doi: 10.2165/11587580-000000000-00000.
3
Different black box warning labeling for same-class drugs.不同同类药物的黑框警告标签。
J Gen Intern Med. 2011 Jun;26(6):603-10. doi: 10.1007/s11606-011-1633-9. Epub 2011 Feb 1.
4
Responding to an FDA warning--geographic variation in the use of rosiglitazone.回应美国食品药品监督管理局的警告——罗格列酮使用的地域差异
N Engl J Med. 2010 Nov 25;363(22):2081-4. doi: 10.1056/NEJMp1011042. Epub 2010 Nov 17.
5
Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.公共药物警戒交流：一个需要基于证据、以目标为导向的策略的过程。
Drug Saf. 2010 Dec 1;33(12):1065-79. doi: 10.2165/11539040-000000000-00000.
6
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases.利培酮或棕榈酸帕利哌酮的长效肌内注射制剂与注射后谵妄/镇静综合征有关吗？安全性数据库评估。
Curr Drug Saf. 2011 Feb 1;6(1):43-5. doi: 10.2174/157488611794480070.
7
Insiders criticise FDA's decision not to withdraw rosiglitazone.业内人士批评美国食品药品监督管理局（FDA）不撤销罗格列酮的决定。
BMJ. 2010 Sep 28;341:c5333. doi: 10.1136/bmj.c5333.
8
Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone.噻唑烷二酮类药物对2型糖尿病患者心血管风险的不同影响：吡格列酮与罗格列酮对比
Curr Drug Saf. 2010 Jul 2;5(3):234-44. doi: 10.2174/157488610791698352.
9
Changes in glitazone use among office-based physicians in the U.S., 2003-2009.美国基层医生中噻唑烷二酮类药物使用的变化，2003-2009 年。
Diabetes Care. 2010 Apr;33(4):823-5. doi: 10.2337/dc09-1834. Epub 2010 Jan 26.
10
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
Zotero 插件